Home Beckley Psytech

Beckley Psytech

acquired
Series B
Psychedelic Drug Developer
Basic
Enterprise Profile

Basic Information

Beckley Psytech is a clinical-stage company dedicated to helping patients with neurological and psychiatric disorders by developing a wide range of psychedelic compounds for both rare and more common diseases. Its vision is to integrate clinically validated psychedelic medicines into modern medical practice to address significant unmet medical needs worldwide.
Beckley Psytech, Ltd.
Oxford,England,United Kingdom
less than 15 people
January 01, 1998
info@beckleypsytech.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
Psychiatry Mental Disorders # Nervous System Diseases Rare Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs